Abstract:
An image forming apparatus forms, on a surface of a moving member moving in a first direction, an image under an image forming condition in accordance with image information. The image forming apparatus includes: a reflection-type optical sensor including an emission system including a plurality of light-emitting units arranged in a second direction perpendicular to the first direction and a light-receiving system including a plurality of light-receiving units that receive reflected light resulting from reflection of emission light emitted from the emission system at the surface of the moving member; and a determination device that determines whether there is an abnormality on the surface of the moving member on the basis of output signals from at least two or more light-receiving units.
Abstract:
A reflective optical sensor detects a position and/or a toner density of the toner pattern. The reflective optical sensor includes an illuminating system that has at least three light-emitting units, a light-receiving system that has at least three light-receiving units and receives light output from the illuminating system and reflected by the toner pattern, and an illuminating optical system that includes at least three illuminating condenser lenses individually corresponding to the at least three light-emitting units and that guides the light output from the illuminating system to the toner pattern. The at least three light-emitting units and the at least three light-receiving units are both arranged in equal distance with respect to one direction. Optical axes of the at least three illuminating condenser lenses are off-center in parallel to an axis passing through a center of and perpendicular to the corresponding light-emitting unit.
Abstract:
Disclosed is an adamantanamine derivative which is useful as a significant intermediate of an 11βHSD-1 inhibitor.Disclosed is a compound represented by the formula (II): wherein R10 is a group represented by the formula: —(CR13R14)m-NR12—R11 or the like.
Abstract translation:公开了一种金刚烷胺衍生物,其可用作11重量%HSD-1抑制剂的重要中间体。 公开了由式(II)表示的化合物:其中R 10是由下式表示的基团: - (CR 13 R 14)m -NR 12 R 11等。
Abstract:
Disclosed is a compound which is useful as an endothelial lipase inhibitor.A compound represented by the formula: its pharmaceutically acceptable salt, or a solvate thereof, wherein Ring A is aromatic carbocycle or aromatic heterocycle, Z is —NR5—, —O— or —S—, R5 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl or the like, R1 is hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or the like, R2 and R3 are each independently hydrogen, halogen, hydroxy or the like, R4 is a group represented by the formula: —(CR6R7)n-R8, wherein R6 and R7 are each independently hydrogen, halogen, hydroxy or the like, n is an integer of 0 to 3, R8 is carboxy, cyano, substituted or unsubstituted alkyl or the like, Rx is halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or the like, m is an integer of 0 to 3.
Abstract:
An optical scanning device, which scans a surface to be scanned by light, includes a light source, a coupling optical system, which changes light from the light source into approximately parallel light, a light control reflection member which is disposed in an optical path of the light from the coupling optical system, the light control reflection member defining a diameter of a beam of the light which scans the surface to be scanned, and reflecting a part of the light which is not used for the scanning toward the coupling optical system, and a light detector which receives the light reflected by the light control reflection member via the coupling optical system.
Abstract:
Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor.A compound represented by the formula: , its pharmaceutically acceptable salt, or a solvate thereof, wherein Ring A is a group represented by the formula: Ring B is optionally substituted heteroaryl, provided that optionally substituted isoxazole is excluded, or optionally substituted heterocycle, R1 is hydrogen or optionally substituted alkyl, R2 is —OR5, —SR5, halogen, halogenated alkyl or the like, R3 is optionally substituted alkyl or the like, R4 is optionally substituted alkyl or the like, R5 is optionally substituted alkyl or the like, R6 is hydrogen or the like, R7 and R8 are each independently hydrogen or the like, R10 and R11 are each independently hydrogen or the like, R12 is optionally substituted alkyl or the like, m and p are each independently integer of 1 to 3.
Abstract translation:公开了可用作11-羟基类固醇脱氢酶1型抑制剂的化合物。 由下式表示的化合物,其药学上可接受的盐或其溶剂合物,其中环A是下式表示的基团:环B是任选取代的杂芳基,条件是排除任选取代的异唑或任选取代的杂环,R 1 R 3为任选取代的烷基等,R 4为任选取代的烷基等,R 5为任选取代的烷基等,R 5为任选取代的烷基, R 6是氢等,R 7和R 8各自独立地为氢等,R 10和R 11各自独立地为氢等,R 12为任选取代的烷基等,m和p各自为1〜3的整数。
Abstract:
An optical element for diffracting a light beam includes a diffractive surface having a one-dimensional periodic structure. The periodic structure and transmissive diffraction efficiencies T′p(m) and T′s(m) of p- and s-polarized lights on the diffractive surface in relation to a diffraction order m satisfy the following conditions: 0.5λ
Abstract:
Disclosed is a compound useful as a type I 11βhydroxysteroid dehydrogenase inhibitor.A compound represented by the formula: a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted alkyl or the like, one of R2 and R4 is a group of formula: —Y—R5, wherein Y is —O— or the like, R5 is substituted alkyl (the substituent is optionally substituted cycloalkyl or the like), optionally substituted branched alkyl or the like, the other of R2 and R4 is hydrogen or optionally substituted alkyl, R3 is a group of formula: —C(═O)-Z-R6, wherein Z is —NR7— or —NR7—W—, R6 is optionally substituted cycloalkyl or the like, R7 is hydrogen or optionally substituted alkyl, W is optionally substituted alkylene, X is ═N— or the like, with the proviso that compounds wherein R2 is 2-(morphorino)ethoxy, R3 is N-(1-adamantyl)carbamoyl and R1 is benzyl are excluded.
Abstract:
An optical scanning device includes a laser light source that emits a laser beam; a light deflector that deflects the laser beam; a scan-imaging optical system that focuses the laser beam deflected from the light deflector on a scanning surface to optically scan the scanning surface; a diffractive optical element receives the laser beam and diffracts a portion of the laser beam as a diffracted light; and a detecting unit that detects the diffracted light. The laser light source is a surface-emitting laser light source. Moreover, the diffractive optical element is made of plastic material having a linear expansion coefficient within a temperature variation range of the optical scanning device nearly equal to a rate of wavelength change of an emission wavelength of the laser light source within the temperature variation range.
Abstract:
An image transmission apparatus and method for use with at least two transmission paths having different transmission rates from one another. The image transmission apparatus comprises an image input for receiving an image signal, a coding processing unit for encoding the image signal, a protocol control unit for packetizing the data encoded by the coding processing unit to generate data packets for transmission, and a transmission unit for transmitting the data packets. The protocol control unit has at least one timer processing unit which controls a data packet transmission interval individually corresponding to the transmission rates of the respective transmission paths based on data packet discard ratio information from the transmission paths.